Top Markets
#1 DogBull DogBull +104.72%
#2 Siacoin Siacoin +47.20%
#3 UnifAI Network UnifAI Network +46.69%
#4 ADO Protocol ADO Protocol +46.51%
#5 MarsCoin MarsCoin +40.40%
#6 Magma Finance Magma Finance +27.08%
#7 Useless Coin Useless Coin +25.34%
#8 Ontology Gas Ontology Gas +19.36%
#9 Nockchain Nockchain +17.04%
#10 Arowana Arowana +15.55%
Coin of the day
DogBull DogBull
Settings
Language
ENGLISH
Currency
USD
Theme
Myriad Genetics, Inc. Myriad Genetics, Inc.

Myriad Genetics, Inc.

MYGN
Rank in Stocks #16435
Myriad Genetics, Inc., a molecular diagnostics and precision medicine company,... Myriad Genetics, Inc., a molecular diagnostics and precision medicine company, develops molecular tests. The company offers molecular diagnostic tests for oncology, women’s health, and pharmacogenomics. It also provides MyRisk Hereditary Cancer test, a DNA sequencing test for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic test, a DNA sequencing test for metastatic breast, ovarian, metastatic pancreatic, and metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. In addition, the company offers Prolaris Prostate Cancer Prognostic test, an RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic test, an RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor Molecular Profile test, a genomic profiling test; Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus; Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; SneakPeek Early Gender DNA test, a non-invasive blood test that predicts the gender of a fetus; FirstGene; and GeneSight Psychotropic Mental Health Medication test, a DNA genotyping test to aid psychotropic drug selection for depression, anxiety, attention-deficit/hyperactivity disorder, and other mental health conditions. It has a license collaboration with Illumina, Inc.; University of Texas M.D. Anderson Cancer Center; Mayo Foundation for Medical Education and Research; Children’s Medical Center in Boston; Institut Curie and INSERM; and Eurobio Scientific SA. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
Share Price
$3.12
Market Cap
$294.21M
Change (1 day)
-3.26%
Change (1 year)
-51.10%
Country
US
Trade Myriad Genetics, Inc. (MYGN)

Category

Healthcare
Stock price history for Myriad Genetics, Inc. (MYGN)
Highest end of day price: $3.12 on 2026-09-01

Lowest end of day price: $6.26 on 1995-10-01
Stock price history of Myriad Genetics, Inc. from 1995 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -18.04%
2025 -52.58%
2024 -26.48%
2023 13.37%
2022 -33.36%
2021 39.65%
2020 -28.26%
2019 -13.46%
2018 -10.65%
2017 93.59%
2016 -59.78%
2015 23.94%
2014 43.88%
2013 -11.52%
2012 33.91%
2011 -9.35%
2010 -9.34%
2009 -21.06%
2008 31.47%
2007 54.75%
2006 52.27%
2005 -8.28%
2004 76.12%
2003 -21.79%
2002 -71.64%
2001 -35.93%
2000 374.80%
1999 284.52%
1998 -60.30%
1997 -0.15%
1996 -23.04%
1995 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Thermo Fisher Scientific Inc. Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc.
TMO.US
 $600.47 21.87%
US
Danaher Corporation Danaher Corporation
Danaher Corporation
DHR.US
 $206.90 0.52%
US
WuXi AppTec Co., Ltd. WuXi AppTec Co., Ltd.
WuXi AppTec Co., Ltd.
603259.SS
 $22.13 41.40%
CN
Natera, Inc. Natera, Inc.
Natera, Inc.
NTRA.US
 $324.57 92.91%
US
IDEXX Laboratories, Inc. IDEXX Laboratories, Inc.
IDEXX Laboratories, Inc.
IDXX.US
 $545.33 -15.73%
US